摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10-乙酰氧基奥卡西平 | 113952-21-9

中文名称
10-乙酰氧基奥卡西平
中文别名
奥卡西平杂质
英文名称
5-carbamoyl-10,11-dihydro-11-oxo-5H-dibenzazepine-10-yl acetate
英文别名
10-Acetyloxy Oxcarbazepine;(11-carbamoyl-5-oxo-6H-benzo[b][1]benzazepin-6-yl) acetate
10-乙酰氧基奥卡西平化学式
CAS
113952-21-9
化学式
C17H14N2O4
mdl
——
分子量
310.309
InChiKey
ZKWJEEHQNGPADU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >187°C (Subl.)
  • 溶解度:
    可溶于丙酮、氯仿、DMSO(轻微)、乙酸乙酯(轻微、加热)、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    89.7
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:ee6c79f2b7d550eb459c84e6e833bf35
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    10-乙酰氧基奥卡西平吡啶二异丁基氢化铝 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 18.5h, 生成 cis-5-carbamoyl-10,11-dihydro-5H-dibenzazepine-10,11-diyl diacetate
    参考文献:
    名称:
    的合成反式-10,11-二氢-10,11-二羟基-5- ħ二苯并[ b,˚F ]氮杂-5-甲酰胺,卡马西平的主要代谢产物
    摘要:
    从10,11-二氢-分两步制备5-氨基甲酰基-10,11-二氢-11-氧代-5 H -dibenz [ b,f ]氮杂-10-乙酸酯(6)的立体选择性研究了10-oxo-5 H -dibenz [ b,f ] azepine -5-carboxamide(4)。在使用的试剂中,发现二异丁基氢化铝(DIBAH)具有最高的反式/顺式二醇比。这允许制备卡马西平的重要的反式-二醇代谢物3(1)。
    DOI:
    10.1002/hlca.19870700730
  • 作为产物:
    描述:
    奥卡西平碘苯二乙酸溶剂黄146 作用下, 反应 16.0h, 以27%的产率得到10-乙酰氧基奥卡西平
    参考文献:
    名称:
    Complementation of Biotransformations with Chemical C–H Oxidation: Copper-Catalyzed Oxidation of Tertiary Amines in Complex Pharmaceuticals
    摘要:
    The isolation, quantitation, and characterization of drug metabolites in biological fluids remain challenging. Rapid access to oxidized drugs could facilitate metabolite identification and enable early pharmacology and toxicity studies. Herein, we compared biotransformations to classical and new chemical C-H oxidation methods using oxcarbazepine, naproxen, and an early compound hit (phthalazine 1). These studies illustrated the low preparative efficacy of biotransformations and the inability of chemical methods to oxidize complex pharmaceuticals. We also disclose an aerobic catalytic protocole (CuI/air) to oxidize tertiary amines and benzylic CH's in drugs. The reaction tolerates a broad range of functionalities and displays a high level of chemoselectivity, which is not generally explained by the strength of the C-H bonds but by the individual structural chemotype. This study represents a first step toward establishing a chemical toolkit (chemotransformations) that can selectively oxidize C-H bonds in complex pharmaceuticals and rapidly deliver drug metabolites.
    DOI:
    10.1021/ja405471h
点击查看最新优质反应信息

文献信息

  • HECKENDORN, ROLAND, HELV. CHIM. ACTA, 70,(1987) N 7, 1955-1962
    作者:HECKENDORN, ROLAND
    DOI:——
    日期:——
  • Complementation of Biotransformations with Chemical C–H Oxidation: Copper-Catalyzed Oxidation of Tertiary Amines in Complex Pharmaceuticals
    作者:Julien Genovino、Stephan Lütz、Dalibor Sames、B. Barry Touré
    DOI:10.1021/ja405471h
    日期:2013.8.21
    The isolation, quantitation, and characterization of drug metabolites in biological fluids remain challenging. Rapid access to oxidized drugs could facilitate metabolite identification and enable early pharmacology and toxicity studies. Herein, we compared biotransformations to classical and new chemical C-H oxidation methods using oxcarbazepine, naproxen, and an early compound hit (phthalazine 1). These studies illustrated the low preparative efficacy of biotransformations and the inability of chemical methods to oxidize complex pharmaceuticals. We also disclose an aerobic catalytic protocole (CuI/air) to oxidize tertiary amines and benzylic CH's in drugs. The reaction tolerates a broad range of functionalities and displays a high level of chemoselectivity, which is not generally explained by the strength of the C-H bonds but by the individual structural chemotype. This study represents a first step toward establishing a chemical toolkit (chemotransformations) that can selectively oxidize C-H bonds in complex pharmaceuticals and rapidly deliver drug metabolites.
  • Synthesis oftrans-10,11-Dihydro-10,11-dihydroxy-5H-dibenz[b,f]azepine-5-carboxamide, a Major Metabolite of Carbamazepine
    作者:Roland Heckendorn
    DOI:10.1002/hlca.19870700730
    日期:1987.11.4
    has been studied. Among the reagents used, diisobutylaluminum hydride (DIBAH) was found to give the highest trans/cis diol ratio. This allowed the preparation of the important trans-diol metabolite 3 of carbamazepine (1).
    从10,11-二氢-分两步制备5-氨基甲酰基-10,11-二氢-11-氧代-5 H -dibenz [ b,f ]氮杂-10-乙酸酯(6)的立体选择性研究了10-oxo-5 H -dibenz [ b,f ] azepine -5-carboxamide(4)。在使用的试剂中,发现二异丁基氢化铝(DIBAH)具有最高的反式/顺式二醇比。这允许制备卡马西平的重要的反式-二醇代谢物3(1)。
查看更多